Genome-wide Association Study of Pituitary Tumors

Pituitary Adenomas Clinical Trial

Official title:

Genome-wide Association Study of Pituitary Tumors

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01442220
• Other study ID #: KY2011-277
• Status: Recruiting
• Phase: N/A
• First received: September 26, 2011
• Last updated: September 27, 2011
• Start date: September 2011
• Est. completion date: July 2014

Study information

• Verified date: September 2011
• Source: Huashan Hospital
• Contact: Yao Zhang, Dr.
• Phone: 86-13916872553
• Email: zhaoyaohs[@]vip.sina.com
• Is FDA regulated: No
• Health authority: China: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

Pituitary adenomas is a very common disease, but the cause and genetics hasn't been identified. The investigators are going to use genome-wide association study to identify genes that may be related to pituitary adenomas.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 12500
• Est. completion date: July 2014
• Est. primary completion date: June 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• patients diagnosed with pituitary adenomas

Exclusion Criteria:

• patients with a family history of endocrine tumors

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pituitary Adenomas
• Pituitary Diseases
• Pituitary Neoplasms

Locations

Country	Name	City	State
China	Huashan Hospital	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Huashan Hospital

Country where clinical trial is conducted

China,